This paper is in the following e-collection/theme issue:

Mobile Health (mhealth) (2939) mHealth in a Clinical Setting (615) Public Health Informatics (93)

Published on in Vol 18, No 6 (2016): Jun

Feasibility and Limitations of Vaccine Two-Dimensional Barcoding Using Mobile Devices

Feasibility and Limitations of Vaccine Two-Dimensional Barcoding Using Mobile Devices

Feasibility and Limitations of Vaccine Two-Dimensional Barcoding Using Mobile Devices

Authors of this article:

Cameron Bell1 Author Orcid Image ;   Katherine M. Atkinson1, 2 Author Orcid Image ;   Julien Guerinet1 Author Orcid Image ;   Kumanan Wilson1, 3 Author Orcid Image
Article Authors Cited by (5) Tweetations (6) Metrics

Journals

  1. Reed J, Evanson H, Cox R, Williams W, Vallero J, Caughron S, Rodgers L, Greene M, Koeppl P, Gerlach K. Improving Utilization of Vaccine Two-Dimensional (2D) Barcode Scanning Technology Maximizes Accuracy Benefits. Journal for Healthcare Quality 2021;43(1):39 View
  2. Jarrett S, Wilmansyah T, Bramanti Y, Alitamsar H, Alamsyah D, Krishnamurthy K, Yang L, Pagliusi S. The role of manufacturers in the implementation of global traceability standards in the supply chain to combat vaccine counterfeiting and enhance safety monitoring. Vaccine 2020;38(52):8318 View
  3. Vander Stichele R, Hay C, Fladvad M, Sturkenboom M, Chen R. How to ensure we can track and trace global use of COVID-19 vaccines?. Vaccine 2021;39(2):176 View
  4. Evanson H, Reed J, Cox R, Clinthorne A, Williams W, Vallero J, Rodgers L, Greene M, Koeppl P, Gerlach K. Improving Staff Experience With Vaccine Data Entry With 2D Barcode Scanning. Journal of Nursing Care Quality 2021;36(2):143 View
  5. Atkinson K, Ntacyabukura B, Hawken S, El-Khatib Z, Laflamme L, Wilson K. Parent and family characteristics associated with reported pediatric influenza vaccination in a sample of Canadian digital vaccination platform users. An exploratory, cross-sectional study in the 2018-2019 influenza season. Human Vaccines & Immunotherapeutics 2024;20(1) View